Skip to main content

Publisher: Wiley-Blackwell

Volume 37, Number 1, 1 February 2012

Optimal therapy for reduction of lipoprotein(a)
pp. 1-3(3)
Authors: Lippi, G.; Targher, G.

Favourites:
ADD

The evolving understanding of the analgesic mechanism of action of flupirtine
pp. 4-6(3)
Authors: Raffa, R. B.; Pergolizzi Jr, J. V.

Favourites:
ADD
Favourites:
ADD

Effect of vitamins C and E on antioxidant status of breast‐cancer patients undergoing chemotherapy
pp. 22-26(5)
Authors: Suhail, N.; Bilal, N.; Khan, H. Y.; Hasan, S.; Sharma, S.; Khan, F.; Mansoor, T.; Banu, N.

Favourites:
ADD

Analysis of antibiotic utilization and bacterial resistance changes in a surgical clinic of Clinical Centre, Nis
pp. 32-36(5)
Authors: Velickovic‐Radovanovic, R.; Petrovic, J.; Kocic, B.; Antic, S.; Mitic, R.

Favourites:
ADD

Socio‐demographic differences in adherence to evidence‐based drug therapy after hospital discharge from acute myocardial infarction: a population‐based cohort study in Rome, Italy
pp. 37-44(8)
Authors: Kirchmayer, U.; Agabiti, N.; Belleudi, V.; Davoli, M.; Fusco, D.; Stafoggia, M.; Arcà, M.; Barone, A. P.; Perucci, C. A.

Favourites:
ADD
Favourites:
ADD

Renal impairment after laparoscopic radical nephrectomy affects hypoglycaemic therapy
pp. 49-52(4)
Authors: Mizuno, T.; Ito, K.; Miyagawa, Y.; Kimura, K.; Suzuki, Y.; Mizuno, M.; Ito, Y.; Funahashi, Y.; Hattori, R.; Gotoh, M.; Noda, Y.; Yamada, K.

Favourites:
ADD

Content variability of active drug substance in compounded oral 3,4‐diaminopyridine products
pp. 53-57(5)
Authors: Green, D. M.; Jones, A. C.; Brain, K. R.

Favourites:
ADD

Impact of out‐of‐pocket expenses on discontinuation of statin therapy: a cohort study in Finland
pp. 58-64(7)
Authors: Helin‐Salmivaara, A.; Korhonen, M.J.; Alanen, T.; Huupponen, R.

Favourites:
ADD

Thiazolidenediones induce tumour‐cell apoptosis through the Akt‐GSK3β pathway
pp. 65-70(6)
Authors: Zhu, H.; Han, B.; Pan, X.; Qi, H.; Xu, L.

Favourites:
ADD

A stability indicating assay for a combination of morphine sulphate with levomepromazine hydrochloride used in palliative care
pp. 71-73(3)
Authors: Al‐Tannak, N. F.; Cable, C. G.; McArthur, D. A.; Watson, D. G.

Favourites:
ADD

Influence of calcium channel blockers in patients with gastrointestinal disease in Japanese community pharmacies
pp. 74-77(4)
Authors: Hamada, A.; Akiyoshi, R.; Ishii, J.; Hamada, N.; Miyazaki, C.; Hamada, T.; Ohwaki, Y.; Ikeda, R.; Wada, M.; Nakashima, K.

Favourites:
ADD

Consumption of three most widely used analgesics in six European countries
pp. 78-80(3)
Authors: Hudec, R.; Božeková, L.; Tisoňová, J.

Favourites:
ADD

Evaluation of steady‐state pharmacokinetic interactions between ritonavir‐boosted BILR 355, a non‐nucleoside reverse transcriptase inhibitor, and lamivudine/zidovudine in healthy subjects
pp. 81-88(8)
Authors: Huang, F.; Allen, L.; Huang, D. B.; Moy, F.; Vinisko, R.; Nguyen, T.; Rowland, L.; MacGregor, T. R.; Castles, M. A.; Robinson, P.

Favourites:
ADD

Rapid and validated fluorometric HPLC method for determination of gabapentin in human plasma and urine for clinical application
pp. 89-94(6)
Authors: Yagi, T.; Naito, T.; Mino, Y.; Takashina, Y.; Umemura, K.; Kawakami, J.

Favourites:
ADD
Favourites:
ADD

Cytochrome P450 3A4 genetic polymorphisms and post‐operative fentanyl requirements
pp. 100-104(5)
Authors: Tan, P. C. S.; Hassan, S. K.; Mohamad, N. A. N.; Gan, S. H.

Favourites:
ADD

Frequency of CYP2C9 variant alleles, including CYP2C9*13 in a Korean population and effect on glimepiride pharmacokinetics
pp. 105-111(7)
Authors: Lee, H. W.; Lim, M.‐s.; Lee, J.; Jegal, M.‐Y.; Kim, D.‐W.; Lee, W.‐K.; Jang, I.‐J.; Shin, J.‐G.; Yoon, Y.‐R.

Favourites:
ADD

Influence of leukotriene pathway polymorphisms on clinical responses to montelukast in Japanese patients with asthma
pp. 112-116(5)
Authors: Kotani, H.; Kishi, R.; Mouri, A.; Sashio, T.; Shindo, J.; Shiraki, A.; Hiramatsu, T.; Iwata, S.; Taniguchi, H.; Nishiyama, O.; Iwata, M.; Suzuki, R.; Gonda, H.; Niwa, T.; Kondo, M.; Hasegawa, Y.; Kume, H.; Noda, Y.

Favourites:
ADD

Eternacept for the treatment of patients with rheumatoid arthritis and concurrent interstitial lung disease
pp. 117-121(5)
Authors: Horai, Y.; Miyamura, T.; Shimada, K.; Takahama, S.; Minami, R.; Yamamoto, M.; Suematsu, E.

Favourites:
ADD
Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more